Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11013728 Cyclin-dependent kinase 8 and/or 19 inhibitor

Patent 11013728 was granted and assigned to Kyoto Pharmaceutical Industries on May, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Kyoto Pharmaceutical Industries

Current Assignee

Kyoto Pharmaceutical Industries

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

May 25, 2021

Patent Application Number

16500395

Date Filed

April 2, 2018

Patent Citations

US Patent 10059663 Aromatic compound and use thereof

Patent Primary Examiner

Taofiq A. Solola

Patent abstract

The present invention aims to provide a novel cyclin-dependent kinase 8 and/or 19 inhibitor useful as an anti-cancer agent. The present invention relates to a cyclin-dependent kinase 8 and/or 19 inhibitor containing a compound represented by the formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11013728 Cyclin-dependent kinase 8 and/or 19 inhibitor

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.